David P. Meeker Salary and Compensation - RHYTHM PHARMACEUTICALS, INC. CEO Salary 2025

In fiscal year 2025, David P. Meeker, Chief Executive Officer of RHYTHM PHARMACEUTICALS, INC. (RYTM), received total compensation of $17.5 million.

David P. Meeker's compensation breakdown includes: base salary of $808K, stock awards valued at $8.3 million, option awards of $7.7 million, non-equity incentive compensation of $759K, and other compensation of $14K.

Compared to fiscal year 2024, David P. Meeker's total compensation increased 20% from $14.7 million to $17.5 million.

RHYTHM PHARMACEUTICALS, INC. (RYTM) Executive Pay 2025

RHYTHM PHARMACEUTICALS, INC.'s top 5 named executive officers received combined total compensation of $39.9 million in fiscal year 2025.

The named executive officers disclosed in RHYTHM PHARMACEUTICALS, INC.'s 2025 proxy statement are:David P. Meeker (Chief Executive Officer) with total compensation of $17.5 million, Hunter C. Smith (Chief Financial Officer) with total compensation of $6.2 million, Yann Mazabraud (Executive Vice President,) with total compensation of $6.1 million, Jennifer Lee (Executive Vice President,) with total compensation of $5.6 million, and Alastair Garfield (Chief Scientific Officer) with total compensation of $4.4 million.